Cargando…

Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?

BACKGROUND: Recent data from the ACOSOG Z0011 trial suggest that axillary lymph node dissection (ALND) may not be necessary for patients with positive sentinel lymph node biopsy (SLNB) receiving breast-conserving surgery (BCS) with irradiation. However, consensus statements and guidelines have recom...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Ji Young, Lee, Eun Sook, Lim, Siew Kuan, Kwon, Youngmee, Jung, So-Youn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325642/ https://www.ncbi.nlm.nih.gov/pubmed/37427099 http://dx.doi.org/10.3389/fonc.2023.1181069

Ejemplares similares

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
por: Si, Jing, et al.
Publicado: (2022)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

Axillary sentinel lymph node biopsy after mastectomy: a case report
por: Vicente, Diego A, et al.
Publicado: (2010)

A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
por: Yang, Hanzhao, et al.
Publicado: (2023)

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
por: Santivasi, Wil L., et al.
Publicado: (2014)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort
por: Jo, Heein, et al.
Publicado: (2020)

Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

Erector Spinae Plane Block for Effective Analgesia after Total Mastectomy with Sentinel or Axillary Lymph Node Dissection: a Report of Three Cases
por: Kwon, Woo Jin, et al.
Publicado: (2018)

Preoperative Nomogram for Predicting Sentinel Lymph Node Metastasis Risk in Breast Cancer: A Potential Application on Omitting Sentinel Lymph Node Biopsy
por: Hu, Xi’E, et al.
Publicado: (2021)

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Mokbel, Kefah, et al.
Publicado: (2023)

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)

A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection
por: Kootstra, Jan J., et al.
Publicado: (2010)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Correction to: Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Same‐day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer
por: Tamminen, Anselm, et al.
Publicado: (2022)

Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019)

Imprint Cytology Predicts Axillary Node Status in Sentinel Lymph Node Biopsy
por: Bell, Zarina, et al.
Publicado: (2010)

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection
por: Campbell, Ian, et al.
Publicado: (2023)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Quality of Life After Axillary or Groin Sentinel Lymph Node Biopsy, With or Without Completion Lymph Node Dissection, in Patients With Cutaneous Melanoma
por: de Vries, Mattijs, et al.
Publicado: (2009)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial
por: Houvenaeghel, Gilles, et al.
Publicado: (2021)

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
por: Kil, Won Ho, et al.
Publicado: (2014)

Author response to: Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Gentile, Damiano, et al.
Publicado: (2023)

Population-Level Impact of Omitting Axillary Lymph Node Dissection in Early Breast Cancer Women: Evidence from an Economic Evaluation in Germany
por: Nguyen, Hoa Thi, et al.
Publicado: (2022)

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer
por: Li, Jianyi, et al.
Publicado: (2015)

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
por: de Boniface, Jana, et al.
Publicado: (2017)

Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients
por: Peintinger, F, et al.
Publicado: (2003)

Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
por: TAKAMARU, TOMOKO, et al.
Publicado: (2014)

Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer
por: Gherghe, M, et al.
Publicado: (2015)

ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iqk71ri4i8sjt7l5rlg1pib6eu